FNA: Paragon 28 Inc. Company Total Debt

Corporate company logo of Paragon 28 Corp (FNA)

The price action history for Paragon 28, Inc. (FNA) debt reflects the impact of operating losses driven by an inflated headcount and promotion costs, with the indicator standing at 0.11. The business generates revenue from unique foot bone fixation kits, providing physicians with comprehensive solutions. Revenue stability is supported by an aging population and crisis-resistant demand for orthopedic interventions.

paragon28.com (FNA): Company Aggregate Debts from 07/04/2022 to 04/26/2025

Analytical breakdowns for Paragon 28, Inc. (FNA)

- current quotes and average value forecast:
Market Price paragon28.com|FNA - Analyst Consensus Forecast
- market capitalization information:
Market Valuation Paragon 28 Corp|FNA - Enterprise Value
- book value of equity indicators:
Net Assets per Share Paragon 28|FNA - Book Capitalization|Market Capitalization to Book Value Ratio paragon28.com|FNA - Aggregate Company Assets
- debt obligations and liquidity statistics:
Debt to Equity Paragon 28, Inc.|FNA - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient paragon28.com|FNA - Company Total Debt|Debts to Book Capitalization Ratio Paragon 28 Corp|FNA - Company Long-Term Debts|Short-Term Debt Paragon 28
Summary company analytics:Paragon 28 Inc. - FNA
Product sample of Paragon 28 Inc.

Professional managers utilize fundamental metrics to filter assets, assessing total leverage as an indicator of financial stability and default risk. Analyzing this debt load in conjunction with GURU.Markets data reveals the extent to which the production scaling of high-tech implants at Paragon 28, Inc. (FNA) relies on loans, a trend clearly reflected in the debt dynamics.

Competing companies

BSX - Company Cumulative Debt|Company Aggregate Debts EW (Edwards Lifesciences)|RMD - Company Total Debt|Insulet - Company Aggregate Debts|Company Total Debt Obligations zimmerbiomet.com ZBH|COO: Company Aggregate Debts|Align Corp (ALGN) - Company Aggregate Debts|Company Debts Globus Medical, Inc.|Company Debts TMDX|Company Aggregate Debts ATEC|Company Total Debt Obligations CryoLife|DJO Global - Company Total Debt|IART (Integra LifeSciences Inc.) - Company Aggregate Indebtedness|Establishment Labs - Company Aggregate Debts|Company Cumulative Debt betabionics.com|IRMD: Company Aggregate Debts|Company Aggregate Debt EMBC|Company Total Debt TNDM|AXGN: Aggregate Debt Obligations|Company Debts SI-BONE, Inc. (SIBN)|Company Total Debt orthofix.com OFIX|Company Aggregate Debts BVS (Bioventus)|OrthoPediatrics Corp (KIDS) - Company Cumulative Debt|Treace Medical - Company Aggregate Debts|SRTA (Strata Medical) - Company Aggregate Debt|CARL: Company Aggregate Debts|RXST - Company Total Debt Obligations|CLPT (ClearPoint Neuro Inc.) - Company Aggregate Debts|Company Total Debt Stereotaxis Inc (STXS)|Company Aggregate Debts STIM|Company Aggregate Debts Sight Sciences Inc (SGHT)|Company Debts Orchestra BioMed, Inc. OBIO|Anika Therapeutics Inc. - Company Debts|NSPR: Company Total Debt|Aggregate Debt Obligations ZJYL (Jin Medical International)|VANI: Company Aggregate Debts|Company Cumulative Debt Xtant Medical (XTNT)|Company Debts NeuroOne Medical Technologies|MODD - Company Total Indebtedness|Company Total Debt MYO (Myomo)|Company Aggregate Debts Envoy Medical Inc. (COCH)|Company Aggregate Debts VVOS (Vivos Therapeutics, Inc)|Company Total Debt Obligations enVVeno Corp (NVNO)|SINT - Company Debts|Company Aggregate Indebtedness TNON|Lifeward (LFWD) - Company Debts|Company Total Debt Autonomix Medical|IVF (INVO Bioscience, Inc.) - Company Aggregate Debts|Company Cumulative Debt Bone Biologics Inc BBLG|Company Debts Axonics, Inc. (AXNX)|biolase.com - Company Aggregate Debt|Dynatronics - Company Total Debt|Company Cumulative Indebtedness INVO (INVO Bioscience Inc.)